SKIN stock

Is Beauty Health Co (SKIN) overvalued? · rev $334.3M

Beauty Health Co (SKIN) is a household & personal products company listed on US.

This page asks whether Beauty Health Co (SKIN) looks expensive on cached numbers — not a short thesis.

Latest reported SKIN revenue for 2024-12-31 was $334.3M. Net income was -$29.1M. Revenue was down 16.0% from 2023-12-31 to 2024-12-31. SKIN currently screens at market cap $287.3M.

SKIN currently screens at market cap $287.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next SKIN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the SKIN stock page for the full model, not this heading.

Not investment advice.

Full SKIN analysis